Google taps Apple Watch nemesis Masimo for exclusive Wear OS health upgrades
Courts blocked Apple from enabling blood oxygen sensors in the Apple Watch due to patent infringement on medical device company Masimo, which holds over 1,500 medical technology patents. Google has now partnered with Masimo and Qualcomm to create health-focused Wear OS reference platforms,
Wear OS watches might soon have an edge when it comes to blood oxygen
Last week, medical device maker Masimo announced new deals with Google and Qualcomm to bring its biosensing tech to Wear OS smartwatches. That’s pretty inside baseball for the wearable industry, but it takes an interesting turn when you realize Masimo is also the reason why the new Apple Watch Series 10 doesn’t have blood oxygen features in the US.
After Forcing Apple Watch Ban, Masimo Now Partners with Google for Health Features
Masimo, the company that forced Apple to remove the Blood Oxygen feature, has partnered with Google to improve Wear OS health tracking.
Google teams with Masimo to revive wear OS smartwatch diversity
Will the new strategy work? The world of smartwatch technology is constantly evolving, and Google plays a key role in it. Although,
New Wear OS watches will get health upgrades from the company that almost got the Apple Watch banned
With the help of Google, Masimo, a health tech giant, is building a new reference platform with upgraded health tracking on Wear OS.
Apple Watch Series 10 review: Is it time to upgrade?
The Apple Watch Series 10 pairs a thinner and lighter design with bigger displays for an improved new feel on the wrist. Sleep apnea detection, faster charging, and a stellar color selection round out ...
Business Wire6d
Masimo Partners with Qualcomm to Develop Next-Generation Smartwatch Reference Platform for Original Equipment Manufacturers
Masimo is partnering with Qualcomm Technologies to develop a comprehensive reference platform to expand the Wear OS by Google™ ecosystem.
medtechdive10h
Masimo investor claims proxy war win as CEO Kiani fails to retain board seat
Politan Capital Management said its candidates captured two board seats in Thursday’s shareholder vote, citing a preliminary analysis.
Nasdaq10d
MASI Stock Down Despite New SafetyNet Deal for Neonatal Care
Masimo Corporation MASI ... wireless continuous monitoring and spot-check devices with an easy-to-use pulse oximetry sensor and an intuitive smartphone application. Health data from the sensor ...
AOL3d
Founder vs. activist: A dramatic two-year battle over health-tech firm Masimo comes to a head this week
Kiani has been in it since starting Masimo in 1989. Along with being chairman and CEO, he holds more than 500 patents or patent applications related to advanced signal processing, optical sensors ...
medtechdive1d
Masimo proxy fight nears end as shareholder vote looms
Koffey was elected to Masimo’s board in June 2023 along with Politan-backed candidate Michelle Brennan, a former Johnson & Johnson executive. The hedge fund argued that Masimo’s $1 billion acquisition ...
SmartHouse4d
Masimo Slips In Google Qualcomm Oxygen Deal Ahead Of Brutal Court Fight
Finally, the explosive Masimo AGM is set down for next week but not before another fight in US Courts which Masimo executives ...
FierceBiotech11h
Politan prevails in Masimo proxy fight, gaining 2 board seats and ousting CEO Joe Kiani
Masimo’s long-running proxy fight has come to a close, at least for now. | Masimo’s long-running proxy fight has come to a ...
Orange County Business Journal4d
Masimo to Hold Pivotal Shareholder Meeting
The future of an iconic Orange County medtech entrepreneur – who was once compared to Steve Jobs – is at stake this week.